Expression and activity of cyclin-dependent kinase 5/p35 in adult rat peripheral nervous system

Journal of Neurochemistry

Volumn 71, Issue 6, 1998, Pages 2600-2606

  Terada, Masahiko ^a   Yasuda, Hitoshi ^a   Kogawa, Syuro ^a   Maeda, Kengo ^a   Haneda, Masakazu ^a   Hidaka, Hideki ^a   Kashiwagi, Atsunori ^a   Kikkawa, Ryuichi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Anterior horn cell; Cyclin dependent kinase 5; Dorsal root ganglion; P35; Sciatic nerve

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 5; PROTEIN P35; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTERIOR HORN CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; NERVE FIBER; NEUROFILAMENT; NONHUMAN; PERIKARYON; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCIATIC NERVE; SPINAL GANGLION;

EID: 0031797323     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71062600.x     Document Type: Article

References (41)

1. Azzi L., Meijer L., Ostvold A.-C., Lew J., and Wang J. H. (1994) Purification of a 15-kDa cdk4- and cdk5-binding protein. J. Biol. Chem. 269, 13279-13288.
2. nck5ai mRNA) during rat brain development. Neurosci. Res. 28, 355-360.
3. Carden M. J., Trojanowski J. Q., Schlaepfer W. W., and Lee V. M.-Y. (1987) Two stage expression of neurofilament polypeptides during rat neurogenesis with early establishment of adult phosphorylation patterns. J. Neurosci. 7, 3489-3504.
4. Chae T., Kwon Y. T., Bronson R., Dikkes P., Li E., and Tsai L. H. (1997) Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defect, seizures, and adult lethality. Neuron 18, 29-42.
5. Delalle I., Bhide P. G., Caviness V. S. Jr., and Tsai L.-H. (1997) Temporal and spatial patterns of expression of p35, a regulatory subunit of cyclin-dependent kinase 5 in the nervous system of the mouse. J. Neurocytol. 26, 283-296.
6. de Waegh S. M., Lee V. M.-Y., and Brady S. T. (1992) Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 73, 451-463.
7. Gu Y., Turck C. W., and Morgan D. O. (1993) Inhibition of cdk2 activity in vivo by an associated 20K regulatory subunit. Nature 366, 707-710.
8. Guidato S., McLoughlin D. M., Grierson A. J., and Miller C. C. J. (1998) Cyclin D2 interacts with cdk-5 and modulates cellular cdk-5/p35 activity. J. Neurochem. 70, 335-340.
9. Hellmich M. R., Pant H. C., Wada E., and Battey J. F. (1992) Neuronal cdc2-related protein kinase with predominantly neuronal expression. Proc. Natl. Acad. Sci. USA 89, 10867-10871.
10. Hirano A. (1991) Cytopathology of amyotrophic lateral sclerosis. Adv. Neurol. 56, 91-102.
11. Ino H., Ishizuka T., Chiba T., and Tatibana M. (1994) Expression of CDK5 (PSSALRE kinase), a neural cdc2-related protein kinase, in mature and developing mouse central and peripheral nervous systems. Brain Res. 661, 196-206.
12. nck5a in early stages of rat cerebellum neurogenesis; tyrosine dephosphorylation and activation in post-mitotic neurons. Neurosci. Lett. 218, 21-24.
13. Lee V. M.-Y., Otvos L. Jr., Carden M. J., Hollosi M., Dietzschold B., and Lazzarini R. (1988) Identification of the major multiphosphorylation site in mammalian neurofilaments. Proc. Natl. Acad. Sci. USA 85, 1998-2002.
14. Lew J., Beaudette K., Litwin C. M. E., and Wang J. H. (1992a) Purification and characterization of novel proline-directed protein kinase from bovine brain. J. Biol. Chem. 267, 13383-13390.
15. cdc2. J. Biol. Chem. 267, 25922-25926.
16. Lew J., Huang Q. Q., Qi Z., Winkfein R. J., Aebeersold R., Hunt T., and Wang J. H. (1994) A brain specific activator of cyclin-dependent kinase 5. Nature 371, 423-426.
17. Lewis S. E. and Nixon R. A. (1988) Multiple phosphorylated variants of the high molecular mass subunit of neurofilaments in axons of retinal cell neurons: characterization and evidence for their differential association with stationary and moving neurofilaments. J. Cell Biol. 107, 2689-2701.
18. Mata M., Kupine N., and Fink D. J. (1992) Phosphorylation-dependent neurofilament epitopes are reduced at the node of Ranvier. J. Neurocytol. 21, 199-210.
19. Matsushita M., Matsui H., Itano T., Tomizawa K., Tokuda M., Suwaki H., Wang J. H., and Hatase O. (1995) Developmental changes of cyclin dependent kinase 5 subcellular localization in the rat cerebellum. Neuroreport 6, 1267-1270.
20. Matsuura I. and Wang J. H. (1996) Demonstration of cyclin-dependent kinase inhibitory serine/threonine kinase in bovine thymus. J. Biol. Chem. 271, 5443-5450.
21. Medri R., Autilio-Gambetti L., Jenich H., and Gambetti P. (1988a) Changes in axon size and slow axonal transport are related in experimental diabetic neuropathy. Neurology 38, 597-601.
22. Medri R., Autilio-Gambetti L., Monaco S., and Gambetti P. (1988b) Experimental diabetic neuropathy: impairment of slow transport with changes in axon cross-sectional area. Proc. Natl. Acad. Sci. USA 82, 7716-7720.
23. Murray A. W. and Kirschner M. W. (1989) Dominoes and clocks: the union of two views of the cell cycle. Science 246, 614-621.
24. Nikolic M., Dudek H., Kwon Y. T., Ramos Y. F. M., and Tsai L.-H. (1996) The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev. 10, 816-825.
25. Nixon R. A., Lewis S. E., and Morotta C. A. (1987) Post-translational modification of neurofilament proteins by phosphate during axoplasmic transport in retinal ganglion cell neurons. J. Neurosci. 7, 1145-1158.
26. Nixon R. A., Paskevich P. A., Sihag R. K., and Thayer C. Y. (1994) Phosphorylation on carboxyl terminus domains of neurofilament proteins in retinal ganglion cell neurons in vivo: influences on regional neurofilament accumulation, interneurofilament spacing, and axon caliber. J. Cell Biol. 126, 1031-1046.
27. Nurse P. (1990) Universal control mechanism regulating onset of M-phase. Nature 344, 503-508.
28. Ohshima T., Ward J. M., Huh C.-G., Longenecker G., Veeranna, Pant H. C., Brady R. O., Martin L. J., and Kulkarni A. B. (1996) Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc. Natl. Acad. Sci. USA 93, 11173-11178.
29. Pines J. (1993) Cyclin and cyclin-dependent kinase: take your partners. Trends Biochem. Sci. 18, 195-197.
30. kip1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8, 9-22.
31. Sherr C. J. (1993) Mammalian G1 cyclins. Cell 73, 1059-1065.
32. Shetty K. T., Link W. T., and Pant H. C. (1993) cdc2-like kinase from rat spinal cord specifically phosphorylates KSPXK motifs in neurofilament proteins: isolation and characterization. Proc. Natl. Acad. Sci. USA 90, 6844-6848.
33. Sun D., Leug C. L., and Liem R. K. (1996) Phosphorylation of the high molecular weight neurofilament protein (NF-H) by cdk5 and p35. J. Biol. Chem. 271, 14245-14251.
34. Tang D., Yeung J., Lee K.-Y., Matsushita M., Matsui H., Tomizawa K., Hatase O., and Wang J. H. (1995) An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator. J. Biol. Chem. 270, 26897-26903.
35. Terada M., Yasuda H., and Kikkawa R. (1998) Delayed Wallerian degeneration and increased neurofilament phosphorylation in sciatic nerves of rats with streptozocin-induced diabetes. J. Neurol. Sci. 155, 23-30.
36. nck3a) in the rat brain. Neuroscience 74, 519-529.
37. Trojanowski J. Q., Schmidt M. L., Shin R.-W., Bramblett G. T., Rao D., and Lee V. M.-Y. (1993) Altered tau and neurofilament proteins in neurodegenerative diseases: diagnostic implications for Alzheimer's disease and Lewy body dementias. Brain Pathol. 3, 45-54.
38. Tsai L.-H., Takahashi T., Caviness V. S. Jr., and Harlow E. (1993) Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development 119, 1029-1040.
39. Tsai L. H., Delalle I., Caviness V. S. Jr., Chae T., and Harlow E. (1994) p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371, 419-423.
40. Xiong Y., Hannon G. J., Zhang H., Casso D., Kobayashi R., and Beach D. (1993) p21 is a universal inhibitor to cyclin kinases. Nature 366, 701-704.
41. Zhang Q., Ahuja H. S., Zahra Z. F., and Wolgemuth D. J. (1997) Cyclin-dependent kinase 5 is associated with apoptotic cell death during development and tissue remodeling. Dev. Biol. 183, 222-233.